Ameritas Investment Partners’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-9,484
| Closed | -$656K | – | 3258 |
|
2024
Q1 | $656K | Hold |
9,484
| – | – | 0.02% | 739 |
|
2023
Q4 | $679K | Buy |
9,484
+174
| +2% | +$12.5K | 0.02% | 715 |
|
2023
Q3 | $485K | Buy |
9,310
+1,572
| +20% | +$81.9K | 0.02% | 782 |
|
2023
Q2 | $490K | Buy |
7,738
+555
| +8% | +$35.1K | 0.02% | 770 |
|
2023
Q1 | $389K | Hold |
7,183
| – | – | 0.02% | 838 |
|
2022
Q4 | $349K | Hold |
7,183
| – | – | 0.01% | 869 |
|
2022
Q3 | $334K | Buy |
7,183
+312
| +5% | +$14.5K | 0.02% | 856 |
|
2022
Q2 | $392K | Buy |
6,871
+701
| +11% | +$40K | 0.02% | 818 |
|
2022
Q1 | $378K | Buy |
6,170
+600
| +11% | +$36.8K | 0.01% | 880 |
|
2021
Q4 | $292K | Hold |
5,570
| – | – | 0.01% | 1006 |
|
2021
Q3 | $208K | Hold |
5,570
| – | – | 0.01% | 1179 |
|
2021
Q2 | $227K | Hold |
5,570
| – | – | 0.01% | 1152 |
|
2021
Q1 | $189K | Hold |
5,570
| – | – | 0.01% | 1260 |
|
2020
Q4 | $177K | Hold |
5,570
| – | – | 0.01% | 1223 |
|
2020
Q3 | $143K | Buy |
5,570
+981
| +21% | +$25.2K | 0.01% | 1219 |
|
2020
Q2 | $118K | Hold |
4,589
| – | – | 0.01% | 1312 |
|
2020
Q1 | $71K | Buy |
4,589
+850
| +23% | +$13.2K | ﹤0.01% | 1462 |
|
2019
Q4 | $128K | Hold |
3,739
| – | – | 0.01% | 1366 |
|
2019
Q3 | $28K | Hold |
3,739
| – | – | ﹤0.01% | 2218 |
|
2019
Q2 | $49K | Hold |
3,739
| – | – | ﹤0.01% | 1926 |
|
2019
Q1 | $46K | Hold |
3,739
| – | – | ﹤0.01% | 1931 |
|
2018
Q4 | $43K | Hold |
3,739
| – | – | ﹤0.01% | 1905 |
|
2018
Q3 | $81K | Sell |
3,739
-450
| -11% | -$9.75K | ﹤0.01% | 1696 |
|
2018
Q2 | $74K | Buy |
4,189
+517
| +14% | +$9.13K | ﹤0.01% | 1750 |
|
2018
Q1 | $77K | Hold |
3,672
| – | – | ﹤0.01% | 1657 |
|
2017
Q4 | $53K | Buy |
3,672
+708
| +24% | +$10.2K | ﹤0.01% | 1897 |
|
2017
Q3 | $54K | Hold |
2,964
| – | – | ﹤0.01% | 1855 |
|
2017
Q2 | $37K | Hold |
2,964
| – | – | ﹤0.01% | 2100 |
|
2017
Q1 | $48K | Buy |
+2,964
| New | +$48K | ﹤0.01% | 1883 |
|